Low-cost, point-of-care biomarker quantification.
Curr Opin Biotechnol
; 76: 102738, 2022 08.
Article
in English
| MEDLINE | ID: covidwho-2130541
ABSTRACT
Low-cost, point-of-care (POC) devices that allow fast, on-site disease diagnosis could have a major global health impact, particularly if they can provide quantitative measurement of molecules indicative of a diseased state (biomarkers). Accurate quantification of biomarkers in patient samples is already challenging when research-grade, sophisticated equipment is available; it is even more difficult when constrained to simple, cost-effective POC platforms. Here, we summarize the main challenges to accurate, low-cost POC biomarker quantification. We also review recent efforts to develop and implement POC tools beyond qualitative readouts, and we conclude by identifying important future research directions.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Point-of-Care Systems
Type of study:
Prognostic study
/
Qualitative research
Limits:
Humans
Language:
English
Journal:
Curr Opin Biotechnol
Journal subject:
Biotechnology
Year:
2022
Document Type:
Article
Affiliation country:
J.copbio.2022.102738
Similar
MEDLINE
...
LILACS
LIS